• 06/06/2026: Lancement des travaux de l'atelier technique sur l'auto-évaluation du système réglementaire national de pharmaceutique, avec la participation des responsables des ministères de l'Industrie pharmaceutique et de la Santé, ainsi que de l'Agence nationale des produits pharmaceutiques et d'experts de l'Organisation mondiale de la Santé.

 

Youtube  X-twitter 

Facebook

 

 

site map

 

consultation notices

E-participation

Quality POLICY AND COMMITMENT

 

Pharmaceutical Industry Policy  

 

Photo Photo Photo Photo
Axis 1 : Ensuring the continuous availability of pharmaceutical products, with a particular focus on essential medicines.

Through the creation of a monitoring and surveillance device for the availability of pharmaceutical products, Continuous monitoring of import and domestic production programs, the updating of the essential medicines list, and the evaluation of import volumes according to market demand and current stock levels.

Axis2 :Implementation of tools and a regulatory framework to ensure quality, efficiency, and safety

The National Agency for Pharmaceutical Products ANPP is strengthened in human and material resources, the drug registration and medical device approval commissions, sits on the intersectoral economic committee for medicines as well as the committee of clinical experts.

Axis 3 :
Developing the national pharmaceutical industry as a wealth-generating sector and promoting investment.

Through the implementation of a new pricing procedure, the prioritization of the registration of generic medicines and similar biotherapeutic products, and the improved management of raw material import programmes.

Axis 4 :Guaranteeing equitable and affordable access to pharmaceutical products for all citizens

By expediting the approval process for pharmaceutical establishments, encouraging subcontracting, and promoting exports through the redirection of several investment projects towards local manufacturing for export purposes.The public group Saidal is benefiting from a development plan designed to establish it as a public hub ensuring national health sovereignty.

sondageDigital services satisfaction survey

 

Plateforme

 


Tabadol Intadj

Plateforme Numérique

Plateforme Tabaadol

Plateform « تبادل – إنتاج »

Online submission of digitized application files for the licensing of pharmaceutical establishments and the manufacturing of pharmaceutical products and medical devices.
Email : tabadol@miph.gov.dz

Note N° 25/MIPP/DPDIPER/2023

Plateform « رؤية »

mproves visibility on the status of medicine stocks throughout the supply chain through:
1-Monthly stock declarations;
2-Reporting of provisional programs;
3-Monthly reporting on implementation progress. ……..More information

Plateforme « تبادل »

Online submission of digitized application files for the licensing of pharmaceutical establishments, import, exploitation, and wholesale distribution of pharmaceutical products and medical devices, Or by email for approval renewals:

Email : tabadol@miph.gov.dz

Note N° 09/DSID/MIP/2023

 


Collection of legal texts

Regulatory reform involves all stages of drug manufacturing, including facilitating investment, good distribution practices and export support.

 

 

Online services

 Substances and drugs with psychotropic properties

 

Application for authorization to transport psychotropic substances
Note N° 936/MIPP/DAPR/2023
Quarterly and annual inventory declaration
Note N° 937/MIPP/DAPR/2023
Declaration and justification of discrepancies in physical stocks
Note N° 937/MIPP/DAPR/2023

Declarations

 

Wholesale Distribution – Reporting of Stock Levels of Pharmaceutical Products
Wholesale Distribution – Reporting of Stock Levels of Medical Devices
-Wholesale Distribution -Inventory of Pharmaceutical Products and Medical Devices
Note N° 18/DSID/2023
Pharmaceutical import establishments – Annual report on import operations
Legal Reference
Monthly declaration of medical device stock levels

Note N° 102/DSID/MIPP/2023

 

Monthly declaration of import operations
Note N° 293/DAPR/2022
Declarations of Export Operations
Monitoring of export operations for pharmaceutical products, medical devices and services
Note N°08/MIPP/DPPP/2024
Declaration of expired products
Note N° 284/MIP/DAPR/2022
Legal Reference

Diverse

 

Portal for declaring provisional import programs submission of provisional import programs for the 2025 financial year
Note N°467/MIPP/DAPR/2024
Provisional Export ProgramsSubmission of provisional export programmes for the 2024 financial year
Note N° 24/MIPP/DPDIPER/2023
REQUETEMEDIC
Any person who is a victim of illegal commercial practices relating to medicines may now bring their complaint directly to the attention of the Department of the Pharmaceutical Industry
Claim form
ANPP: Illegal Marketing of Pharmaceutical Products
Portal for Technical Pharmacist Directors of Pharmaceutical Establishments
 Note N°03/MIPP/DPDIPER/2024

The Pharmaceutical Industry in Algeria

 

PictoA_noun_426774-300x300 Etudesclinique promotion-imp EPH
How to Obtain a License for a Pharmaceutical Establishment
The application for a license for a pharmaceutical establishment The application for a license for a pharmaceutical establishment must be accompanied by a file containing the following documents: >> read more.
Clinical studies
As part of the promotion of clinical studies, research, and development, the Ministry of the Pharmaceutical Industry is planning favorable measures to support clinical research activities and innovation in the pharmaceutical industry.​
Export promotion
As part of the action plan of the Ministry of Pharmaceutical Industry, the promotion of exports is s a major focus for the development of the sector and its transformation from a budget-consuming sector to a wealth-creating sector.

PRACTICAL GUIDE TO EXPORT PROCEDURES   

Pharmaceutical Establishments
List of Pharmaceutical Establishments Approved by the Ministry of Pharmaceutical Industry​

 

x002 obs x003 02_1g2_pharma_solution_serialization_588680006_header_800x530-800x530
Strategic monitoring
A systematic, continuous, ethical, and legal process for collecting, analysing, processing, and disseminating information.
Mechanism for Monitoring and Surveillance of the Availability of Pharmaceutical Products

La liste de l’Observatoire de Veille des médicaments disponibles en officine

 

Regulation and pharmaceutical activities
Regulatory certificate Approval
Import/Distribution/exploitation
File : The Serialization of Medicines
Serialization is the process of assigning unique identifiers to individual products and/or individual product packages in order to be able to readily identify and track the products and/or packages. Serialization bestows a unique, protected identity to each serialized item.


contexte-pharmacologie-produits-pharmaceutiques-espace-copie-illustration-ia-generative_839051-1682

NOMENCLATURE – 30 APRIL 2026
Form for reporting discrepancies and omissions


in the National List of Pharmaceutical Products for Human Use

Pharmaceutical establishments are requested to submit their observations regarding the nomenclature of their pharmaceutical products within one (1) month from the date of publication of the latest version of the National Nomenclature of Pharmaceutical Products for Human Use.

 

Videotheque


 

 

 

 

 

Ministry of Pharmaceutical Industry © 2021. All rights reserved.